Tscan Therapeutics, Inc.(TCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TCRX Tscan Therapeutics, Inc.

交易中 09-18 12:20:47 EDT

5.54

+0.09

+1.65%

最高5.61	最低5.43	成交量19.08万
今开5.45	昨收5.45	日振幅3.30%
总市值2.93亿	流通市值1.42亿	总股本5,297万
成交额105.06万	换手率0.74%	流通股本2,568万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TCRX","market":"US","secType":"STK","nameCN":"Tscan Therapeutics, Inc.","latestPrice":5.54,"timestamp":1726676443688,"preClose":5.45,"halted":0,"volume":190755,"delay":0,"floatShares":25681647,"shares":52973870,"eps":-1.972559,"marketStatus":"交易中","marketStatusCode":2,"change":0.09,"latestTime":"09-18 12:20:47 EDT","open":5.45,"high":5.61,"low":5.43,"amount":1050556.266045,"amplitude":0.033028,"askPrice":5.57,"askSize":102,"bidPrice":5.54,"bidSize":1311,"shortable":3,"etf":0,"ttmEps":-1.972559,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1726689600000},"adr":0,"listingDate":1626408000000,"adjPreClose":5.45,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5.45,"preClose":5.45,"latestTime":"09:00 EDT","volume":10,"amount":54.5,"timestamp":1726664440526},"postHourTrading":{"tag":"盘后","latestPrice":5.45,"preClose":5.45,"latestTime":"18:02 EDT","volume":5100,"amount":27795.16,"timestamp":1726610520833},"volumeRatio":2.823406},"requestUrl":"/m/hq/s/TCRX/tweets","defaultTab":"tweets","newsList":[{"id":"2460397068","title":"Tscan Therapeutics, Inc.盘中异动 下午盘快速上涨5.57%报6.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460397068","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460397068?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:24","pubTimestamp":1724091843,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时24分，Tscan Therapeutics, Inc.股票出现波动，股价急速拉升5.57%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为8797.79%、3726.83%、1256.13%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为405.90%、220.18%、198.02%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820022403971992fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820022403971992fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","TCRX"],"gpt_icon":0},{"id":"2460824187","title":"Tscan Therapeutics, Inc.2024财年第二财季实现净利润-31.66百万美元，同比减少31.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460824187","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460824187?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824039,"startTime":"0","endTime":"0","summary":"8月17日，Tscan Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-31.66百万美元，同比减少31.64%；其中营业收入为536000.00美元，同比减少82.98%，每股基本收益为-0.28美元。从资产负债表来看，Tscan Therapeutics, Inc.总负债1.20亿美元，其中短期债务13.95百万美元，资产负债比为3.13，流动比率为0.08。机构评级：截至2024年8月17日，当前有6家机构对Tscan Therapeutics, Inc.目标价做出预测，其中目标均价为12.33美元，其中最低目标价为10.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006189f31b16e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006189f31b16e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","LENZ"],"gpt_icon":0},{"id":"2459479176","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大涨5.33%报5.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459479176","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459479176?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:54","pubTimestamp":1723733669,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时54分，Tscan Therapeutics, Inc.股票出现波动，股价急速上涨5.33%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6209.36%、2019.20%、551.60%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815225430a1d47467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815225430a1d47467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2459648106","title":"Tscan Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459648106","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459648106?lang=zh_cn&edition=full","pubTime":"2024-08-15 02:50","pubTimestamp":1723661421,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日02时50分，Tscan Therapeutics, Inc.股票出现异动，股价大幅下跌5.12%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Virax Biolabs Group Limited、Cormedix Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Geovax Labs, Inc.、Virax Biolabs Group Limited、Genprex, Inc.较为活跃，换手率分别为115.10%、96.77%、94.09%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Virax Biolabs Group Limited，振幅分别为60.83%、58.52%、51.54%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081502502198e34f6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081502502198e34f6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","TCRX"],"gpt_icon":0},{"id":"2459131359","title":"Tscan Therapeutics, Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459131359","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459131359?lang=zh_cn&edition=full","pubTime":"2024-08-14 03:21","pubTimestamp":1723576877,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日03时21分，Tscan Therapeutics, Inc.股票出现异动，股价大幅跳水5.00%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.07%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814032117968260d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814032117968260d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRX","LENZ","BK4539"],"gpt_icon":0},{"id":"2458986189","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458986189","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458986189?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469512,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分，Tscan Therapeutics, Inc.股票出现异动，股价快速下跌5.24%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Oragenics Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Revance Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为37.74%、19.04%、8.54%，振幅较大的相关个股有Sangamo Therapeutics, Inc.、Oragenics Inc.、Abcellera Biologics Inc.，振幅分别为22.55%、22.50%、12.69%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213152aefe6ac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213152aefe6ac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRX","LENZ","BK4539"],"gpt_icon":0},{"id":"2457348285","title":"Tscan Therapeutics, Inc.盘中异动 股价大涨5.04%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457348285","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457348285?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:58","pubTimestamp":1723129103,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时58分，Tscan Therapeutics, Inc.股票出现波动，股价快速上涨5.04%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为3.09%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为331.02%、282.99%、177.66%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为74.12%、54.41%、42.63%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080822582496825332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080822582496825332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","TCRX","BK4139","LENZ"],"gpt_icon":0},{"id":"2457987513","title":"Tscan Therapeutics, Inc.盘中异动 下午盘快速跳水5.22%报5.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457987513","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457987513?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:48","pubTimestamp":1723056499,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日02时48分，Tscan Therapeutics, Inc.股票出现异动，股价快速下跌5.22%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.63%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5172.37%、2695.49%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、62.37%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808024819941ff1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808024819941ff1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","TCRX"],"gpt_icon":0},{"id":"2457079625","title":"Tscan Therapeutics, Inc.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457079625","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457079625?lang=zh_cn&edition=full","pubTime":"2024-08-07 00:41","pubTimestamp":1722962495,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日00时41分，Tscan Therapeutics, Inc.股票出现异动，股价快速下跌5.12%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080700413698e34c85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080700413698e34c85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","TCRX","BK4139","LENZ"],"gpt_icon":0},{"id":"2456540134","title":"Tscan Therapeutics, Inc.盘中异动 下午盘大幅下挫5.04%报6.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456540134","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456540134?lang=zh_cn&edition=full","pubTime":"2024-08-02 01:37","pubTimestamp":1722533863,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日01时37分，Tscan Therapeutics, Inc.股票出现波动，股价急速跳水5.04%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Immuneering Corporation涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为2595.98%、352.75%、215.75%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Renovaro Inc.、Virax Biolabs Group Limited，振幅分别为59.30%、45.25%、43.37%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080201374496822c5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080201374496822c5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","TCRX"],"gpt_icon":0},{"id":"2455619694","title":"Tscan Therapeutics, Inc.盘中异动 股价大跌5.09%报6.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455619694","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455619694?lang=zh_cn&edition=full","pubTime":"2024-07-30 01:52","pubTimestamp":1722275565,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日01时52分，Tscan Therapeutics, Inc.股票出现异动，股价急速跳水5.09%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2418.77%、796.84%、240.02%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为156.69%、75.11%、57.78%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730015245af94a629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730015245af94a629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","TCRX","BK4139","LENZ"],"gpt_icon":0},{"id":"2453968068","title":"Tscan Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报7.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453968068","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453968068?lang=zh_cn&edition=full","pubTime":"2024-07-24 01:03","pubTimestamp":1721754193,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日01时03分，Tscan Therapeutics, Inc.股票出现异动，股价快速拉升5.08%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Azitra Inc、Salarius Pharmaceuticals, Inc.、Gri Bio, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为8622.17%、6272.68%、3603.68%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc，振幅分别为366.13%、365.43%、150.00%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724010314941f9aef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724010314941f9aef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","TCRX","LENZ"],"gpt_icon":0},{"id":"2452458471","title":"Tscan Therapeutics, Inc.盘中异动 下午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452458471","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452458471?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:30","pubTimestamp":1721327426,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日02时30分，Tscan Therapeutics, Inc.股票出现异动，股价快速下挫5.03%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.03%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3206.52%、2573.45%、1294.59%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719023026af9301d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719023026af9301d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2451191848","title":"Tscan Therapeutics, Inc.盘中异动 股价大涨5.00%报7.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451191848","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451191848?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:53","pubTimestamp":1721138006,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时53分，Tscan Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Silo Pharma, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Conduit Pharmaceuticals Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1699.46%、963.00%、91.72%，振幅较大的相关个股有Scisparc Ltd.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为40.48%、40.18%、39.04%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162153269681d324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162153269681d324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","TCRX","BK4139","LENZ"],"gpt_icon":0},{"id":"2450363836","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大涨6.31%报6.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450363836","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450363836?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:48","pubTimestamp":1720705715,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时48分，Tscan Therapeutics, Inc.股票出现异动，股价快速上涨6.31%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Terns Pharmaceuticals, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为459.15%、287.70%、271.23%，振幅较大的相关个股有Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为82.31%、73.13%、39.71%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214835941f6461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214835941f6461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","TCRX"],"gpt_icon":0},{"id":"2449971292","title":"Tscan Therapeutics, Inc.盘中异动 股价大跌5.15%报5.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449971292","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449971292?lang=zh_cn&edition=full","pubTime":"2024-07-06 00:31","pubTimestamp":1720197077,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日00时31分，Tscan Therapeutics, Inc.股票出现异动，股价快速下挫5.15%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Mediwound Ltd.涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.较为活跃，换手率分别为13722.86%、2343.77%、112.52%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.，振幅分别为151.52%、80.46%、46.66%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706003117941f47aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706003117941f47aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2448168765","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448168765","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448168765?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:44","pubTimestamp":1719931464,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日22时44分，Tscan Therapeutics, Inc.股票出现波动，股价急速下跌5.38%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Zura Bio Limited C/Wts 、Mustang Bio, Inc.、Sensei Biotherapeutics, Inc.涨幅较大，Gri Bio, Inc.、Mustang Bio, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为44.71%、37.16%、33.51%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Anew Medical Inc C/Wts 21/06/2029 、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为72.83%、39.76%、39.00%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702224425aef79afc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702224425aef79afc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","TCRX"],"gpt_icon":0},{"id":"2446068597","title":"Tscan Therapeutics, Inc.盘中异动 早盘股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446068597","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446068597?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:53","pubTimestamp":1719582839,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时53分，Tscan Therapeutics, Inc.股票出现异动，股价快速下挫5.37%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821535996818035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062821535996818035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRX","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2446555542","title":"Tscan Therapeutics, Inc.盘中异动 早盘急速拉升5.01%报6.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446555542","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446555542?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:48","pubTimestamp":1719496136,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时48分，Tscan Therapeutics, Inc.股票出现异动，股价急速上涨5.01%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Geovax Labs, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Geovax Labs, Inc.、Nls Pharmaceutics Ltd.、Kala Bio, Inc.较为活跃，换手率分别为360.22%、206.11%、120.96%，振幅较大的相关个股有Geovax Labs, Inc.、Nls Pharmaceutics Ltd.、Effector Therapeutics Inc C/Wts 31/12/2025 ，振幅分别为80.39%、70.04%、66.67%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214856af8f8a3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214856af8f8a3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","TCRX"],"gpt_icon":0},{"id":"2446826476","title":"Tscan Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446826476","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446826476?lang=zh_cn&edition=full","pubTime":"2024-06-26 00:17","pubTimestamp":1719332245,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日00时17分，Tscan Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。Tscan Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.58%。其相关个股中，Cns Pharmaceuticals, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为689.41%、214.10%、172.00%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Glycomimetics, Inc.，振幅分别为77.13%、54.55%、47.00%。Tscan Therapeutics, Inc.公司简介：TScan Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗癌症患者的 T 细胞受体  工程化 T 细胞疗法 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626001725aef68a83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626001725aef68a83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRX","LENZ","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tscan.com","stockEarnings":[{"period":"1week","weight":-0.0794},{"period":"1month","weight":-0.0505},{"period":"3month","weight":-0.2147},{"period":"6month","weight":-0.2225},{"period":"1year","weight":0.8858},{"period":"ytd","weight":-0.0652}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TScan Therapeutics, Inc.于2018年4月17日在特拉华州注册成立。该公司是一家临床前阶段的生物制药公司，专注于开发强大的T细胞受体工程T细胞或TCR-T疗法，用于治疗癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.041343},{"month":2,"riseRate":0.666667,"avgChangeRate":0.270461},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.148391},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.059633},{"month":5,"riseRate":1,"avgChangeRate":0.203034},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.082007},{"month":7,"riseRate":0.666667,"avgChangeRate":0.170793},{"month":8,"riseRate":0.25,"avgChangeRate":-0.151516},{"month":9,"riseRate":0.5,"avgChangeRate":0.02272},{"month":10,"riseRate":0.666667,"avgChangeRate":0.146504},{"month":11,"riseRate":0.333333,"avgChangeRate":0.123511},{"month":12,"riseRate":0,"avgChangeRate":-0.267379}],"exchange":"NASDAQ","name":"Tscan Therapeutics, Inc.","nameEN":"Tscan Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tscan Therapeutics, Inc.(TCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tscan Therapeutics, Inc.(TCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tscan Therapeutics, Inc.,TCRX,Tscan Therapeutics, Inc.股票,Tscan Therapeutics, Inc.股票老虎,Tscan Therapeutics, Inc.股票老虎国际,Tscan Therapeutics, Inc.行情,Tscan Therapeutics, Inc.股票行情,Tscan Therapeutics, Inc.股价,Tscan Therapeutics, Inc.股市,Tscan Therapeutics, Inc.股票价格,Tscan Therapeutics, Inc.股票交易,Tscan Therapeutics, Inc.股票购买,Tscan Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tscan Therapeutics, Inc.(TCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tscan Therapeutics, Inc.(TCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况